EP 1492595 A1 20050105 - THERAPY FOR PSYCHOSES COMBINING AN ATYPICAL ANTIPSYCHOTIC AND AN MGLU2/3 RECEPTOR AGONIST
Title (en)
THERAPY FOR PSYCHOSES COMBINING AN ATYPICAL ANTIPSYCHOTIC AND AN MGLU2/3 RECEPTOR AGONIST
Title (de)
THERAPIE FÜR PSYCHOSEN DIE EIN ATYPISCHES ANTIPSYCHOTIKUM MIT EINEM MGLU2/3 REZEPTOR AGONIST KOMBINIERT
Title (fr)
TRAITEMENT DES PSYCHOSES ASSOCIANT UN ANTIPSYCHOTIQUE ATYPIQUE ET UN ANTAGONISTE DU RECEPTEUR MGLU2/3
Publication
Application
Priority
- US 0307283 W 20030321
- US 36977102 P 20020403
- US 36979702 P 20020403
Abstract (en)
[origin: WO03084610A1] The present invention provides for a pharmaceutical composition and methods for treating psychosis comprising the combination or a first component which is an atypical antipsychotic with a second component which is a mGlu2/3 receptor agonist. The present invention also provides for a pharmaceutical composition and method of treating a psychiatric disorder comprising the combination of a first component which is an atypical antipsychotic with a second component which is a compound which allosterically enhances receptor activity for mGlu2 and/or mGlu3.
IPC 1-7
IPC 8 full level
C07D 243/38 (2006.01); A61K 31/196 (2006.01); A61K 31/343 (2006.01); A61K 31/551 (2006.01); A61K 31/5513 (2006.01); A61K 38/00 (2006.01); A61K 45/06 (2006.01); A61P 25/18 (2006.01); C07D 307/93 (2006.01); C07D 495/04 (2006.01)
CPC (source: EP)
A61K 31/196 (2013.01); A61K 31/551 (2013.01); A61K 31/5513 (2013.01); A61K 45/06 (2013.01); A61P 25/18 (2017.12)
C-Set (source: EP)
Citation (search report)
See references of WO 03084610A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 03084610 A1 20031016; AU 2003218063 A1 20031020; CA 2478227 A1 20031016; EP 1492595 A1 20050105; JP 2005528378 A 20050922
DOCDB simple family (application)
US 0307283 W 20030321; AU 2003218063 A 20030321; CA 2478227 A 20030321; EP 03714045 A 20030321; JP 2003581846 A 20030321